Mauro David J's Form 4 filing
Prelude Therapeutics Inc (PRLD) · filed Jul 8, 2021
- Accession no.
- 0001209191-21-046013
- Filed
- Jul 8, 2021
- Trade date
- Jul 6, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $412.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mauro David JCIK 0001621172 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2021 | Common Stock | MOption exerciseAcquired | +15,000 | $1.89 | +$28,350 | 15,000 | Direct | |
| Jul 6, 2021 | Common Stock | SSaleDisposed | −10,445 | $27.17 | −$283,790.65 | 4,555 | Direct | |
| Jul 6, 2021 | Common Stock | SSaleDisposed | −4,255 | $28.13 | −$119,693.15 | 300 | Direct | |
| Jul 6, 2021 | Common Stock | SSaleDisposed | −300 | $28.84 | −$8,652 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2021 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 182,610 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.